Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML. (Q44037646)

29 November 2017

title

Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML. (English)

1 reference

29 November 2017

Horn B

1

1 reference

29 November 2017

Baxter-Lowe LA

2

1 reference

29 November 2017

Englert L

3

1 reference

29 November 2017

McMillan A

4

1 reference

29 November 2017

Quinn M

5

1 reference

29 November 2017

Desantes K

6

1 reference

29 November 2017

Cowan M

7

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Bone Marrow Transplantation

29 November 2017

published in

1 reference

29 November 2017

volume

37

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

263-269

1 reference

Bone marrow transplantation for sickle cell disease.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Target dose adjustment of busulfan in pediatric patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

inferred from DOI database lookup

7 January 2021

based on heuristic

Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

inferred from DOI database lookup

7 January 2021

based on heuristic

Immune reconstitution after haematopoietic transplantation with two different doses of pre-graft antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705240

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.BMT.1705240

1 reference

29 November 2017

1 reference